HampDTI: a heterogeneous graph automatic meta-path learning method for drug-target interaction prediction

• URL: http://arxiv.org/abs/2112.08567v1
• Date: Thu, 16 Dec 2021 02:12:03 GMT
• Title: HampDTI: a heterogeneous graph automatic meta-path learning method for drug-target interaction prediction
• Authors: Hongzhun Wang, Feng Huang, Wen Zhang
• Abstract summary: We propose a heterogeneous graph automatic meta-path learning based DTI prediction method (HampDTI) HampDTI automatically learns the important meta-paths between drugs and targets from the HN, and generates meta-path graphs. Experiments on benchmark datasets show that our proposed HampDTI achieves superior performance compared with state-of-the-art DTI prediction methods.
• Score: 4.499861098235355
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: Motivation: Identifying drug-target interactions (DTIs) is a key step in drug repositioning. In recent years, the accumulation of a large number of genomics and pharmacology data has formed mass drug and target related heterogeneous networks (HNs), which provides new opportunities of developing HN-based computational models to accurately predict DTIs. The HN implies lots of useful information about DTIs but also contains irrelevant data, and how to make the best of heterogeneous networks remains a challenge. Results: In this paper, we propose a heterogeneous graph automatic meta-path learning based DTI prediction method (HampDTI). HampDTI automatically learns the important meta-paths between drugs and targets from the HN, and generates meta-path graphs. For each meta-path graph, the features learned from drug molecule graphs and target protein sequences serve as the node attributes, and then a node-type specific graph convolutional network (NSGCN) which efficiently considers node type information (drugs or targets) is designed to learn embeddings of drugs and targets. Finally, the embeddings from multiple meta-path graphs are combined to predict novel DTIs. The experiments on benchmark datasets show that our proposed HampDTI achieves superior performance compared with state-of-the-art DTI prediction methods. More importantly, HampDTI identifies the important meta-paths for DTI prediction, which could explain how drugs connect with targets in HNs.

Related papers

• A Heterogeneous Network-based Contrastive Learning Approach for Predicting Drug-Target Interaction [3.1923357295923225]
  Drug-target interaction (DTI) prediction is crucial for drug development and repositioning. We propose a heterogeneous network-based contrastive learning method called HNCL-DTI. Experimental results show that HNCL-DTI outperforms existing advanced baseline methods on benchmark datasets.
  arXiv  Detail & Related papers  (2024-10-20T14:57:24Z)
• MOTIVE: A Drug-Target Interaction Graph For Inductive Link Prediction [0.29998889086656577]
  This paper introduces MOTIVE, a Morphological cOmpound Target Interaction Graph dataset comprising Cell Painting features for 11,000 genes and 3,600 compounds. We provide random, cold-source (new drugs) and cold-target (new genes) data splits to enable rigorous evaluation under realistic use cases. Our benchmark results show that graph neural networks that use Cell Painting features consistently outperform those that learn from graph structure alone.
  arXiv  Detail & Related papers  (2024-06-12T21:18:14Z)
• A Cross-Field Fusion Strategy for Drug-Target Interaction Prediction [85.2792480737546]
  Existing methods fail to utilize global protein information during DTI prediction. Cross-field information fusion strategy is employed to acquire local and global protein information. Siamese drug-target interaction SiamDTI prediction method achieves higher accuracy levels than other state-of-the-art (SOTA) methods on novel drugs and targets.
  arXiv  Detail & Related papers  (2024-05-23T13:25:20Z)
• HiGraphDTI: Hierarchical Graph Representation Learning for Drug-Target Interaction Prediction [15.005837084219355]
  We propose a hierarchical graph representation learning-based DTI prediction method (HiGraphDTI) Specifically, HiGraphDTI learns hierarchical drug representations from triple-level molecular graphs to thoroughly exploit chemical information embedded in atoms, motifs, and molecules. An attentional feature fusion module incorporates information from different receptive fields to extract expressive target features.
  arXiv  Detail & Related papers  (2024-04-16T13:35:24Z)
• Emerging Drug Interaction Prediction Enabled by Flow-based Graph Neural Network with Biomedical Network [69.16939798838159]
  We propose EmerGNN, a graph neural network (GNN) that can effectively predict interactions for emerging drugs. EmerGNN learns pairwise representations of drugs by extracting the paths between drug pairs, propagating information from one drug to the other, and incorporating the relevant biomedical concepts on the paths. Overall, EmerGNN has higher accuracy than existing approaches in predicting interactions for emerging drugs and can identify the most relevant information on the biomedical network.
  arXiv  Detail & Related papers  (2023-11-15T06:34:00Z)
• ResDTA: Predicting Drug-Target Binding Affinity Using Residual Skip Connections [0.0]
  We present a deep learning-based methodology for predicting DT binding affinities using just sequencing information from both targets and drugs. The proposed model achieves the best Concordance Index (CI) performance in one of the largest benchmark datasets.
  arXiv  Detail & Related papers  (2023-03-20T20:27:11Z)
• Drug-Target Interaction Prediction with Graph Attention networks [26.40249934284416]
  We present an end-to-end framework, DTI-GAT (Drug-Target Interaction prediction with Graph Attention networks) for DTI predictions. DTI-GAT incorporates a deep network neural architecture that operates on graph-structured data with the attention mechanism. Experimental evaluations show that DTI-GAT outperforms various state-of-the-art systems on the binary DTI prediction problem.
  arXiv  Detail & Related papers  (2021-07-10T07:06:36Z)
• Distance-aware Molecule Graph Attention Network for Drug-Target Binding Affinity Prediction [54.93890176891602]
  We propose a diStance-aware Molecule graph Attention Network (S-MAN) tailored to drug-target binding affinity prediction. As a dedicated solution, we first propose a position encoding mechanism to integrate the topological structure and spatial position information into the constructed pocket-ligand graph. We also propose a novel edge-node hierarchical attentive aggregation structure which has edge-level aggregation and node-level aggregation.
  arXiv  Detail & Related papers  (2020-12-17T17:44:01Z)
• SumGNN: Multi-typed Drug Interaction Prediction via Efficient Knowledge Graph Summarization [64.56399911605286]
  We propose SumGNN: knowledge summarization graph neural network, which is enabled by a subgraph extraction module. SumGNN outperforms the best baseline by up to 5.54%, and the performance gain is particularly significant in low data relation types.
  arXiv  Detail & Related papers  (2020-10-04T00:14:57Z)
• MolTrans: Molecular Interaction Transformer for Drug Target Interaction Prediction [68.5766865583049]
  Drug target interaction (DTI) prediction is a foundational task for in silico drug discovery. Recent years have witnessed promising progress for deep learning in DTI predictions. We propose a Molecular Interaction Transformer (TransMol) to address these limitations.
  arXiv  Detail & Related papers  (2020-04-23T18:56:04Z)
• DeepPurpose: a Deep Learning Library for Drug-Target Interaction Prediction [69.7424023336611]
  DeepPurpose is a comprehensive and easy-to-use deep learning library for DTI prediction. It supports training of customized DTI prediction models by implementing 15 compound and protein encoders and over 50 neural architectures. We demonstrate state-of-the-art performance of DeepPurpose on several benchmark datasets.
  arXiv  Detail & Related papers  (2020-04-19T17:31:55Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.